Literature DB >> 20921011

Piecewise affine systems modelling for optimizing hormone therapy of prostate cancer.

Taiji Suzuki1, Nicholas Bruchovsky, Kazuyuki Aihara.   

Abstract

Prostate cancer is one of the most common malignant neoplasms in men with an overall incidence of approximately 15 per cent during the normal life span. Androgen-deprivation therapy (hormone therapy) is an effective treatment of this disease when progressed to an advanced stage. Despite impressive responses, such treatment when applied on a continuous basis is not curative and eventually culminates in androgen-independent disease. On the other hand, intermittent androgen suppression (IAS) was first conceived as a potential way of delaying progression to androgen-independence, in addition offering the possibility of reducing adverse effects and improving the quality of life. Although the validity of this approach has been confirmed in several clinical studies, the optimal scheduling of the cycles of on- and off-treatment remains to be explored. In the present article, we show that IAS lends itself to mathematical modelling with hybrid dynamical systems and that the model we have developed can be used to select the best strategy for keeping prostate cancer in an androgen-dependent state as long as possible. Our results also suggest that the current way of using IAS exceeds what is necessary for optimal control; in fact, we have found that to achieve optimal control, the amount of therapy (dose and duration of drugs) can be reduced by a factor of one half.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20921011     DOI: 10.1098/rsta.2010.0220

Source DB:  PubMed          Journal:  Philos Trans A Math Phys Eng Sci        ISSN: 1364-503X            Impact factor:   4.226


  6 in total

1.  Personalizing Androgen Suppression for Prostate Cancer Using Mathematical Modeling.

Authors:  Yoshito Hirata; Kai Morino; Koichiro Akakura; Celestia S Higano; Kazuyuki Aihara
Journal:  Sci Rep       Date:  2018-02-08       Impact factor: 4.379

Review 2.  Mathematically modelling and controlling prostate cancer under intermittent hormone therapy.

Authors:  Yoshito Hirata; Gouhei Tanaka; Nicholas Bruchovsky; Kazuyuki Aihara
Journal:  Asian J Androl       Date:  2012-01-09       Impact factor: 3.285

3.  A partial differential equation model and its reduction to an ordinary differential equation model for prostate tumor growth under intermittent hormone therapy.

Authors:  Youshan Tao; Qian Guo; Kazuyuki Aihara
Journal:  J Math Biol       Date:  2013-08-28       Impact factor: 2.259

4.  Quantitative mathematical modeling of PSA dynamics of prostate cancer patients treated with intermittent androgen suppression.

Authors:  Yoshito Hirata; Koichiro Akakura; Celestia S Higano; Nicholas Bruchovsky; Kazuyuki Aihara
Journal:  J Mol Cell Biol       Date:  2012-05-04       Impact factor: 6.216

5.  Intermittent Androgen Suppression: Estimating Parameters for Individual Patients Based on Initial PSA Data in Response to Androgen Deprivation Therapy.

Authors:  Yoshito Hirata; Kai Morino; Koichiro Akakura; Celestia S Higano; Nicholas Bruchovsky; Teresa Gambol; Susan Hall; Gouhei Tanaka; Kazuyuki Aihara
Journal:  PLoS One       Date:  2015-06-24       Impact factor: 3.240

6.  Predicting disease progression from short biomarker series using expert advice algorithm.

Authors:  Kai Morino; Yoshito Hirata; Ryota Tomioka; Hisashi Kashima; Kenji Yamanishi; Norihiro Hayashi; Shin Egawa; Kazuyuki Aihara
Journal:  Sci Rep       Date:  2015-05-20       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.